Background illustration for clinical trials search

Paid Clinical Trials New Orleans

Discover 511 paid clinical trials in New Orleans, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Location: Metairie LA, Flowood MS, Houston TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05519475

Phase2, Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

for
Peripheral Vascular Diseases
Location: Kenner LA, Tupelo MS, Houston TX, Tallahassee FL,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT04674969

Recruiting

Endoscopic Sutures For Gastrointestinal Tract Disorders: A Prospective Multicenter Registry

for
Endoscopic Suturing Within the Gastrointestinal Tract
Location: Kenner LA, Dallas TX, New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT02166125

Recruiting

Cold and Compression Post TKA

for
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery,
Location: New Orleans LA
Sponsor: Ochsner Health System

Sex: All

Age: 50+

Code: NCT07023185

Recruiting

Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma

for
Barrett Esophagus, Esophageal Cancer
Location: Kenner LA
Sponsor: Ochsner Health System

Sex: All

Age: 18+

Code: NCT03216135

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours

for
Neuroendocrine Tumor
Location: Kenner LA
Sponsor: Nuclear Medicine Consultants, Inc.

Sex: All

Age: 18+

Code: NCT01448083

Recruiting

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
Location: Slidell LA, Tomball TX, Little Rock AR, Dallas TX,
Sponsor: Vasa Therapeutics

Sex: All

Age: 50+

Code: NCT07219511

Phase1, Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Slidell LA, Hammond LA, Mobile AL, Jackson MS,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase3, Recruiting

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

for
Lumbar Spinal Stenosis
Location: Slidell LA, Jupiter FL, Loveland OH, Oxon Hill MD,
Sponsor: Pacific Research Institute

Sex: All

Age: 18+

Code: NCT05504499

Recruiting

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: Slidell LA, Denham Springs LA, Vidalia LA,
Sponsor: Omeza, LLC

Sex: All

Age: 18+

Code: NCT07161830

Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Slidell LA, Birmingham AL, Houston TX, Austin TX,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07091630

Phase3, Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Slidell LA, Birmingham AL, Houston TX, Irving TX,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06920004

Phase3, Recruiting

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for
Uncontrolled Gout
Location: Mandeville LA, Birmingham AL, Houston TX, Sugar Land TX,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07388498

Phase3, Recruiting

Shield Post-Approval Study Protocol

for
Colo-rectal Cancer
Location: Covington LA, Hammond LA, Ridgeland MS, Shenandoah TX,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 45 - 70+

Code: NCT06880055

Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Covington LA, Lafayette LA, Shreveport LA,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase3, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Covington LA, Hammond LA, Hattiesburg MS, Beaumont TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase3, Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Covington LA, Shreveport LA, Kingwood TX, Birmingham AL,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma (MM)
Location: Covington LA, Houston TX, Ocala FL, Springdale AR,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT07477587

Phase1, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Covington LA, Hammond LA, Shelbyville TN,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Covington LA, Jackson MS, Pensacola FL,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting